RSTMH Biennial Meeting

Gave an invited talk on High throughput genetic analysis in Trypanosoma brucei at the biennial RSTMH meeting at Warwick University. It was a diverse meeting, including representatives from malaria, TB, Onchocerca and maternal health research, amongst many others, looking at ‘discovery and delivery of new paradigms for global health’; though my talk was the only one on trypanosomes (also the final one of the day, so not as well attended as I’d hoped!).

Posted in Conference | Comments Off on RSTMH Biennial Meeting

Latest work on histone chaperones and VSG ES regulation published in Nucleic Acids Research.

Cell-cycle-regulated control of VSG expression site silencing by histones and histone chaperones ASF1A and CAF-1b in Trypanosoma brucei. Nucleic Acids Res. (PubMed | PDF)

A longstanding mystery in T. brucei biology is how these parasites are able to express a single variant surface glycoprotein (VSG) from a single sub-telomeric expression site (ES), while repressing at least 14 others. While we cannot claim to have solved this mystery, we have added weight to the contention that chromatin is a key, though probably not the only, player in this process.

We’ve demonstrated that the histone chaperones, CAF-1b and ASF1A, contribute to the maintenance of silent VSG ESs in T. brucei. RNAi depletion of either of these histone chaperones leads to de-repression of the ES promoter, in a cell cycle dependent manner; ASF1A loss led to ES promoter de-repression throughout the cell cycle, while CAF-1b loss resulted in greater de-repression in S and G2/M phases, due to nucleosome depletion. As has been reported for other factors involved in ES silencing, we didn’t see any significant readthrough to the ~50kb distal VSG gene following chaperone depletion; indeed, we saw the same ES promoter de-repression without readthrough when we depleted the cells for histone H3 (a core histone), suggesting that, though chromatin is clearly important to ES silencing, another layer of control exists.

This adds to the weight of evidence for the importance of chromatin in the maintenance VSG expression site silencing – fundamental to the effective monoallelic expression of this abundant family of T. brucei variant surface molecules. This work follows on from that of a number of other groups highlighting a multitude of expression site-influencing chromatin factors, including telomere binding proteins, histone deacetylases, other histone chaperones and components of the nuclear lamina (references below).

DuBois et al (2012) PLoS Biol. 10:e1001287
Narayanan et al (2011) Nucleic Acids Res. 39:2018-31
Stanne et al (2011) Eukaryot. Cell 10:964-76
Wang et al (2010) Mol. Microbiol. 77:1237-45
Denninger et al (2010) Mol. Microbiol. 78:459-74
Yang et al (2009) Cell (2009) 137:99-109
Figueiredo et al (2008) PLoS Biol. 6:e161

Posted in Publication | Comments Off on Latest work on histone chaperones and VSG ES regulation published in Nucleic Acids Research.

A new beginning…

After a productive nine years working as a post-doc in David Horn’s lab, the 1st June 2012 is the day that I get a bit of independence – thanks to the Wellcome Trust Institutional Strategic Support Fund I have the opportunity to build a group and plough my own furrow in Trypanosomiasis research at LSHTM.

Work in the lab will focus on the molecular and cell biology of the African trypanosome, Trypanosoma brucei, with particular emphasis on the parasite’s interaction with its host environment. One approach to this area will be the selection of a bloodstream form RNAi library under various conditions, enabling the identification of parasite factors responsible for the uptake and intracellular transit of environmental, host and parasite-derived molecules; this includes, but is not limited to, drugs, nutrients, innate immune factors and the products of parasite metabolic processes.

This site will provide details of current research in the lab, maintain a summary of past and recent successes, and provide the Trypanosomiasis research community with details of useful resources and protocols. I’ll also post details of any interesting developments, as they occur, such as conferences and job opportunities.